In the last trading session, 12,932,802 shares of the Corbus Pharmaceuticals Holdings, Inc.(NASDAQ:CRBP) were traded, and its beta was 2.13. Most recently the company’s share price was $2.76, and it changed around -$0.16 or -0.05% from the last close, which brings the market valuation of the company to $231.94 Million. CRBP currently trades at a discount to its 52-week high of $9.78, offering almost -254.35% off that amount. The share price’s 52-week low was $0.91, which indicates that the current value has risen by an impressive 67.03% since then. We note from Corbus Pharmaceuticals Holdings, Inc.’s average daily trading volume that its 10-day average is 20.02 Million shares, with the 3-month average coming to 14.74 Million.
Corbus Pharmaceuticals Holdings, Inc. stock received a consensus recommendation rating of Hold, based on a mean score of 2.8. If we narrow it down even further, the data shows that none out of 5 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, 4 recommended CRBP as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight. Corbus Pharmaceuticals Holdings, Inc. is expected to report earnings per share of -$0.25 for the current quarter.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP): Trading Information
Although CRBP has showed a red trend with a performance of -5.48% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $3.16- on Tuesday, Feb 16 increased the stock’s daily price by 12.66%. The company’s shares are currently up 1.21% year-to-date, but still down -0.0769 over the last five days. On the other hand, Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is 0.31% up in the 30-day period. We can see from the shorts that 14.69 Million shares have been sold at a short interest cover period of 1 day(s).
The consensus price target as assigned by Wall Street analysts is $1.88, which translates to bears needing to reduce their stock price by -31.88% from its current value. Analyst projections state that CRBP is forecast to be at a low of $1.22 and a high of $3. In order for the stock price to hit the forecast high, the stock would need to surge +8.7% from its current level, while the stock would need to crash -55.8% from its current level to reach the projected low.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) projections and forecasts
Corbus Pharmaceuticals Holdings, Inc. share prices are not performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -66.05 percent over the past six months and at a -41.96% annual growth rate that is well below the industry average of 17.3%. Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will gain +39% in revenue this quarter, and will report an increase of 65.1% in the next quarter. The year-over-year growth rate is expected to be -86.8%, down from the previous year.
Consensus estimates provided by 5 financial analysts predict the company will bring in an average of $1.49 Million in revenue for the current quarter. 2 analysts expect Corbus Pharmaceuticals Holdings, Inc. to make $1.11 Million in revenue for the quarter ending March 01, 2021. The company’s sales for the same quarters a year ago were $2.57 Million and $1.76 Million respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -42.1%. Forecasts for the next quarter put sales growth at -37%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -61.9%. Corbus Pharmaceuticals Holdings, Inc. earnings are expected to decrease by -14.5% in 2021, but the outlook is negative 0% per year for the next five years.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 1.73% of Corbus Pharmaceuticals Holdings, Inc. shares, and 75.49% of them are in the hands of institutional investors. The stock currently has a share float of 76.82%. Corbus Pharmaceuticals Holdings, Inc. stock is held by 171 institutions, with State Street Corporation being the largest institutional investor. By Sep 29, 2020, it held 19.77% of the shares, which is about 16.62 Million shares worth $29.91 Million.
Blackrock Inc., with 6.21% or 5.22 Million shares worth $6.53 Million as of Dec 30, 2020, holds the second largest percentage of outstanding shares.